Performance analysis of Akari Therapeutics (AKTX)
Annual Return
Over the past 3 years, AKTX has had an average annual return of -58.36%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, AKTX has had an average annual return of -62.51%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, AKTX has had an average annual return of -48.07%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Sep 21, 2015, AKTX has had an average annual return of -51.43%, underperforming the benchmark SPY, which returned +14.92% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -20.00% | -73.68% | -62.00% | -66.44% | -68.70% | -18.91% | +5.58% | +11.65% | -63.78% | -38.48% | -51.44% | -53.97% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -20.00% | +0% | -50.00% | +0% | +250% | -42.86% | -0% | -20.00% | |||||
| 2025 | -10.53% | -17.65% | +42.86% | +15% | -8.70% | -9.52% | -15.79% | -25.00% | +33.33% | -25.00% | -33.33% | -37.50% | -73.68% |
| 2024 | -16.00% | -11.90% | -18.92% | -20.00% | +12.50% | +59.26% | +41.86% | +0% | -22.95% | -19.15% | -50.00% | -0% | -62.00% |
| 2023 | -0.67% | -25.68% | -47.27% | -1.72% | -1.75% | -3.57% | +46.30% | -36.71% | +26% | -14.29% | -12.96% | +6.38% | -66.44% |
| 2022 | -8.61% | -1.38% | -11.19% | -0.79% | -1.85% | -14.56% | +14.20% | +4.42% | -47.09% | -26.00% | +18.24% | -14.86% | -68.70% |
| 2021 | +36.80% | +32.38% | -21.17% | -21.96% | -12.84% | -3.68% | -6.38% | +13.62% | -11.47% | +1.93% | -1.90% | -7.93% | -18.91% |
| 2020 | +2.70% | +2.28% | -21.23% | +32.61% | +6.23% | +6.79% | -7.80% | -14.42% | +1.10% | -13.77% | +6.72% | +15.55% | +5.58% |
| 2019 | +28.11% | -9.87% | +97.74% | +0% | -46.97% | +6.30% | -6.86% | +10.55% | -17.73% | +11.05% | +8.46% | -14.98% | +11.65% |
| 2018 | -33.96% | -31.83% | -6.62% | +4.84% | -3.63% | +5.99% | -1.45% | -2.13% | +36.18% | -29.77% | -0.53% | -12.32% | -63.78% |
| 2017 | +13.65% | -18.62% | +70% | +35.43% | -59.11% | -24.82% | +0.89% | -23.64% | +72.94% | -30.12% | +13.29% | -10.89% | -38.48% |
Drawdown analysis of Akari Therapeutics (AKTX)
The maximum drawdown for the AKTX was -99.99%, occurring on Apr 6, 2026. This drawdown has not yet recovered.
The current AKTX drawdown is -99.96%.
Since Sep 21, 2015 AKTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Sep 21, 2015 | 2649 | Apr 6, 2026 | Ongoing | Ongoing | Ongoing |